
Thrombin-activatable fibrinolysis inhibitor (TAFI) levels and its polymorphism rs3742264 are associated with dyslipidemia in a cohort of Brazilian subjects
Keywords: اختلالات چربی خون یا دیسپیدمی; Dyslipidemia; Fibrinolysis; Polymorphisms; Risk factor; TAFI;